MS Australia Boosts Research with $2.8 Million in New Grants
MS Australia has announced $2.8 million in new research grants, dedicated to projects focused on slowing the progression of Multiple Sclerosis (MS), managing symptoms, and improving the quality of life for individuals with the condition. Over more than two decades, the organization has invested more than $60 million in vital MS research.
MS is an immune-mediated condition where the body attacks the brain and spinal cord, damaging myelin. This damage can profoundly affect mobility, vision, cognition, and energy levels. By 2025, over 37,700 Australians are projected to be living with MS, marking a substantial 77.4% increase since 2010.
The economic impact of MS reached an estimated $3 billion in 2024, underscoring the critical need for continued research and support.
Unpacking the Role of Copper in MS Progression
One particularly promising project, led by Dr. Brittney Lins at Curtin University and Perron Institute, is investigating the crucial role of disrupted copper levels in the brain. Her research aims to determine if copper imbalance connects major MS risk factors, such as Epstein-Barr virus infection, vitamin D deficiency, and gut health. The project seeks to understand if this imbalance contributes directly to myelin damage, with the ultimate goal of identifying new prevention and treatment strategies.
Dr. Lins stated that copper, a vital trace nutrient, plays a critical role in energy utilization and antioxidant defenses. She suggested that if copper use is disrupted, myelin might become more vulnerable to inflammation and autoimmunity, potentially serving as a link between multiple MS risk factors.
Dr. Rebekah Puls, Head of Research at Perron Institute, noted that recent advances in synchrotron microscopy now enable unprecedented imaging of brain copper levels, providing robust support for Dr. Lins' preclinical project. Collaborators on this significant research include Associate Professor Mark Hackett from Curtin University, and Professor Lindy Fitzgerald, Dr. Sarah Hellewell, and Dr. Chidozie Anyaegbu from the Curtin University and Perron Institute Neurotrauma Research group.
Sustained Investment for Future Breakthroughs
MS Australia CEO Rohan Greenland highlighted the importance of sustained national investment in research for continued progress in treating MS. These new research grants represent a crucial step forward.
The new grants will be officially launched at Parliament House in Canberra on March 4, during MS Australia’s "Advancing MS Research in Australia" event. Dr. Monique Ryan MP and Ms. Renee Coffey MP are scheduled to speak at the launch, emphasizing the national significance of this investment.